Actively Recruiting
Study of Fluvoxamine to Reduce Fatigue and Symptoms After COVID-19 Infection Randomized, Placebo-Controlled Trial in Adults Aged 18 to 70 with Post-COVID Conditions
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2026-06-09
160
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate fluvoxamine, a selective serotonin reuptake inhibitor SSRI, for reducing symptoms in adults suffering from post-COVID conditions such as fatigue, cognitive problems, post-exertional malaise PEM, and postural orthostatic tachycardia syndrome POTS. The study explores potential biological pathways involved in post-COVID symptoms through advanced functional neuroimaging and plasma biomarker analysis, addressing the lack of established biomedical treatments for these debilitating effects. Participants are randomly assigned to receive either fluvoxamine or a placebo for 12 weeks in a double-blind manner. The dosing starts with a low amount and is gradually increased every six days up to a maximum daily dose of 200 mg, with flexibility to adjust based on participant tolerance. An optional neuroimaging sub-study uses brain imaging techniques during cognitive challenges to investigate fluvoxamines effects on brain function and structure compared to placebo. Throughout the trial, participants will be assessed at multiple points for fatigue severity, cognitive functioning, PEM, POTS, health-related quality of life, disability, and side effects. Blood samples will be collected to measure inflammatory markers, cortisol, serotonin, and other biochemical pathways to understand treatment mechanisms. Safety and symptom changes are closely monitored, and brain imaging assessments occur for those in the optional sub-study. Total participation covers 12 weeks of treatment with regular evaluations to capture the impact of the intervention.
CONDITIONS
Brief Title
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here